HOME >> BIOLOGY >> NEWS
Joslin President awarded medal from international diabetes organization

BOSTON - C. Ronald Kahn, M.D., President and Director of Joslin Diabetes Center, has been awarded the 2004 Claude Bernard Medal by the European Association for the Study of Diabetes (EASD) at the organization's 40th Annual Meeting in Munich, Germany. This prestigious award recognizes innovative leadership and superior contributions in the field of diabetes research and is the highest scientific honor awarded by the EASD. Dr. Kahn also is the Mary K. Iacocca Professor of Medicine at Harvard Medical School.

As part of the honor, Dr. Kahn presented the distinguished Claude Bernard Lecture, considered to be the highlight of the weeklong EASD annual meeting, which was held Sept. 5-9. Dr. Kahn discussed how communication between the brain and tissues of the body relates to the pathogenesis of diabetes. Dr. Ele Ferrannini, the president of the EASD, presented Dr. Kahn with the Claude Bernard Medal immediately following his lecture on the final day of the meeting, Sept. 9.

Over the past three decades, the research of Dr. Kahn has literally defined the field of insulin signal transduction and mechanisms of altered signaling in disease. In 1981, Dr. Kahn's laboratory discovered that the insulin receptor is an insulin-stimulated enzyme with protein tyrosine kinase activity. His laboratory also demonstrated how insulin signaling is altered in insulin-resistant states, such as type 2 diabetes and obesity; the impact of genetics and environment on these signaling functions; and how knowledge gleaned from these studies can be translated into new treatment methods for people with diabetes.

In recent studies, Dr. Kahn and his colleagues have conducted a series of studies using genetically engineered mice with knocked out insulin receptors in classical target tissues, such as liver, muscle and fat. These experiments indicated the important link between obesity, diabetes and longevity. Using these techniques, Dr. Kahn and collea
'"/>


10-Sep-2004


Page: 1 2 3

Related biology news :

1. Joslin Diabetes Center honors brothers living 70-plus years with type 1 diabetes
2. Joslin researchers clarify mechanisms for beta-cell formation
3. Joslin Diabetes Center adds first affiliate in California at Irvine Medical Center
4. New imaging technology at Joslin shown to detect early signs of type 1 diabetes
5. Joslin Diabetes Center launches research section on developmental and stem cell biology
6. Joslin Diabetes Center releases new low impact exercise video
7. Joslin researchers identify key molecule in Type 1 diabetes progression
8. As obesity skyrockets, Joslin Diabetes Center urges action to stem the tide of type 2 diabetes
9. AAAS US Presidential Candidates Forum
10. US Presidential Candidates Forum
11. Berkeley Lab soil scientist Margaret Torn receives Presidential Early Career Award

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2018)... SEABROOK, N.H. (PRWEB) , ... September 19, 2018 ... ... system integrator of custom industrial automation and IT solutions with 150 employees on ... biotech automation capabilities and accept job applications at the 2018 International Society of ...
(Date:9/22/2018)... DALLAS (PRWEB) , ... September 21, 2018 , ... ... beautiful, worry-free outcome. However, the implant manufacturer’s warranty does not always protect them ... for their breast augmentation with the IDEAL IMPLANT Premium Protection Plan ...
(Date:9/12/2018)... ... September 10, 2018 , ... IONpathTM, a venture-backed commercial-stage ... Multiplexed Ion Beam Imaging (MIBITM) technology was accepted by the journal Cell and ... shared during a webinar presented by Dr. Mike Angelo on October 2nd, 2018. ...
Breaking Biology News(10 mins):
(Date:8/21/2018)... ... 21, 2018 , ... The Connecticut Technology Council (CTC) and Marcum LLP today ... technology companies in Connecticut. This year’s group of top-ranked companies will be honored at ... Connecticut Convention Center in Hartford. A complete list of the Marcum Tech Top 40 ...
(Date:8/17/2018)... , ... August 16, 2018 , ... ... (CRO) is pleased to announce the expansion of their team. Dr. Dawn Dufield, ... to launch an innovative large molecule LC-MS/MS group that will specialize in developing ...
(Date:8/17/2018)... ... August 17, 2018 , ... VANCOUVER, British Columbia, Canada, August ... pleased to announce the release of the Russian translation of Best Practices: Recommendations ... 2018, is a practice-changing publication aimed at advancing the science of biobanking to ...
(Date:8/14/2018)... Calif. (PRWEB) , ... August 14, 2018 , ... ... important drug for treating opioid use disorder. BUP is often prescribed as a ... and diversion. , In this webinar, participants will learn from a review ...
Breaking Biology Technology:
Cached News: